Objective:

To explore the challenges and advancements in drug delivery technologies, particularly focusing on KinetiSol, addressing the increasing prevalence of poorly soluble drugs.

Key Findings:

• The percentage of poorly soluble drugs in pipelines is increasing due to the discovery of complex molecules targeting previously undruggable proteins, which poses significant challenges for formulation.
• Conventional drug delivery methods are becoming inadequate for newer, more complex compounds, necessitating the development of advanced technologies.
• KinetiSol technology offers a solution by using mechanical energy and minimal heat to process drugs, reducing thermal degradation risks and improving solubility.

Interpretation:

The evolution of drug discovery methods necessitates innovative delivery technologies to ensure effective absorption of increasingly complex drug molecules, highlighting the critical role of advancements like KinetiSol.

Limitations:

• Commercial scale manufacturing of new delivery technologies can be complex and costly, particularly for those that do not conform to traditional methods.
• Many new compounds, especially those designed to target complex biological pathways, remain insoluble in both water and organic solvents, complicating formulation processes.

Conclusion:

Advancements in drug delivery technologies, such as KinetiSol, are crucial for overcoming solubility challenges and enabling the development of new therapeutics for chronic diseases, particularly in oncology, where effective delivery is essential.